Treatment of Drug-Susceptible Tuberculosis

doi:10.1513/AnnalsATS.201607-567CME

Comment

. 2016 Nov;13(11):2060-2063.

doi: 10.1513/AnnalsATS.201607-567CME.

Treatment of Drug-Susceptible Tuberculosis

Charles S Dela Cruz¹, Patrick G Lyons², Susan Pasnick³, Tanya Weinstock^{4

5}, Payam Nahid³, Kevin C Wilson⁶, Carey C Thomson^{4

5}

Affiliations

¹ 1 Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut.
² 2 Section of Pulmonary and Critical Care Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
³ 3 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
⁴ 4 Division of Pulmonary Disease and Critical Care Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.
⁵ 5 Harvard Medical School, Boston, Massachusetts; and.
⁶ 6 Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, Boston University Medical Center, Boston, Massachusetts.

PMID: 27831799
DOI: 10.1513/AnnalsATS.201607-567CME

Comment

Treatment of Drug-Susceptible Tuberculosis

Charles S Dela Cruz et al. Ann Am Thorac Soc. 2016 Nov.

. 2016 Nov;13(11):2060-2063.

doi: 10.1513/AnnalsATS.201607-567CME.

Authors

Charles S Dela Cruz¹, Patrick G Lyons², Susan Pasnick³, Tanya Weinstock^{4

5}, Payam Nahid³, Kevin C Wilson⁶, Carey C Thomson^{4

5}

Affiliations

¹ 1 Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut.
² 2 Section of Pulmonary and Critical Care Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
³ 3 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
⁴ 4 Division of Pulmonary Disease and Critical Care Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.
⁵ 5 Harvard Medical School, Boston, Massachusetts; and.
⁶ 6 Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, Boston University Medical Center, Boston, Massachusetts.

PMID: 27831799
DOI: 10.1513/AnnalsATS.201607-567CME

No abstract available

PubMed Disclaimer

Comment on

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Nahid P, et al. Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10. Clin Infect Dis. 2016. PMID: 27516382 Free PMC article.

Cited by

Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018).
Beeler Asay GR, Lam CK, Stewart B, Mangan JM, Romo L, Marks SM, Morris SB, Gummo CL, Keh CE, Hill AN, Thomas A, Macaraig M, St John K, J Ampie T, Chuck C, Burzynski J. Beeler Asay GR, et al. Am J Public Health. 2020 Nov;110(11):1696-1703. doi: 10.2105/AJPH.2020.305877. Epub 2020 Sep 17. Am J Public Health. 2020. PMID: 32941064 Free PMC article.
Pathogenicity and virulence of Mycobacterium tuberculosis.
Rahlwes KC, Dias BRS, Campos PC, Alvarez-Arguedas S, Shiloh MU. Rahlwes KC, et al. Virulence. 2023 Dec;14(1):2150449. doi: 10.1080/21505594.2022.2150449. Virulence. 2023. PMID: 36419223 Free PMC article. Review.
Spinal Tuberculosis Treatment: An Enduring Bone of Contention.
Garg D, Goyal V. Garg D, et al. Ann Indian Acad Neurol. 2020 Jul-Aug;23(4):441-448. doi: 10.4103/aian.AIAN_141_20. Epub 2020 Jul 16. Ann Indian Acad Neurol. 2020. PMID: 33223659 Free PMC article.
Novel Isoniazid-Carborane Hybrids Active in Vitro Against Mycobacterium tuberculosis.
Różycka D, Korycka-Machała M, Żaczek A, Dziadek J, Gurda D, Orlicka-Płocka M, Wyszko E, Biniek-Antosiak K, Rypniewski W, Olejniczak AB. Różycka D, et al. Pharmaceuticals (Basel). 2020 Dec 15;13(12):465. doi: 10.3390/ph13120465. Pharmaceuticals (Basel). 2020. PMID: 33333865 Free PMC article.
Treatment outcomes of pulmonary TB in adults in Indonesia.
Sugiyono RI, Naysilla AM, Susanto NH, Handayani D, Burhan E, Karuniawati A, Kusmiati T, Wibisono BH, Riyanto BS, Sajinadiyasa IGK, Djaharuddin I, Sinaga BYM, Dewantara RD, Karyana M, Kosasih H, Liang CJ, Ridzon R, Neal AT, Chen RY. Sugiyono RI, et al. IJTLD Open. 2025 Mar 12;2(3):145-152. doi: 10.5588/ijtldopen.24.0482. eCollection 2025 Mar. IJTLD Open. 2025. PMID: 40092521 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Treatment of Drug-Susceptible Tuberculosis

Affiliations

Treatment of Drug-Susceptible Tuberculosis

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical